Difficulties in differential diagnosis of COPD and asthma in primary care

British Journal of General Practice

Volumn 62, Issue 595, 2012, Pages

  Miravitlles, Marc ^a   Andreu, Isabel ^b   Romero, Yolanda ^b   Sitjar, Salvador ^c   Alteś, Andreu ^d   Anton, Esther ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b CAP Numancia   (Spain)

^c CAP Les Corts   (Spain)

^d CAP Sans   (Spain)

^e PFIZER INC   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Diagnosis; Inhaled corticosteroids; Primary care

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LONG ACTING BETA AGONIST; SALBUTAMOL; SHORT ACTING BETA AGONIST; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SOCIAL ASPECT; SPAIN; SPIROMETRY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; ASTHMA; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 84856861808     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X625111     Document Type: Article

References (32)

1. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64(10): 863-868.
2. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43(1): 75-80.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD. http://www.goldcopd. org/uploads/users/files/GOLD-Report-2011Dec30.pdf (accessed 9 Jan 2012)
4. Global Initiative for Asthma (GINA). GINA report: global strategy for asthma management and prevention. http://www.ginasthma.org/uploads/users/files/ GINA-Report-2011.pdf (accessed 9 Jan 2012)
5. Flor-Escriche X, Rodríguez-Mas M, Espiau M, et al. Compliance with guidelines in the treatment of asthma exacerbations in primary care. Ther Adv Respir Dis 2011; 5(6): 369-375.
6. van Schayck CP, Levy ML, Stephenson P, Sheikh A. The IPCRG Guidelines: developing guidelines formanaging chronic respiratory diseases in primary care. Prim Care Respir J 2006; 15(1): 1-4. (Pubitemid 43155760)
7. Peces-Barba G, Barberà JA, Agustí A, et al. [Diagnosis andmanagement of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]. Arch Bronconeumol 2008; 44(5): 271-281.
8. Miravitlles M, de la Roza C, Naberan K, et al. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007; 101(8): 1753-1760. (Pubitemid 46947875)
9. Naberan K, De la Roza C, Lamban M, et al. [Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol 2006; 42(12): 638-644.
10. Halpin DM, O'Reilly JF, Connellan S, et al. Confidence and understanding among general practitioners and practice nurses in the UK about diagnosis and management of COPD. Respir Med 2007; 101(11): 2378-2385. (Pubitemid 47471397)
11. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006; 73(3): 296-305. (Pubitemid 43725786)
12. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176(2): 162-166. (Pubitemid 47057852)
13. Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009; 34(3): 641-647.
14. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review andmeta-analysis. JAMA 2008; 300(20): 2407-2416.
15. Izquierdo JL, Martín A, de Lucas P, et al. Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis 2010; 5: 241-249.
16. No authors listed. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3): 1107-1136.
17. Beeh KM, Kornmann O, Beier J, et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004; 98(7): 591-597. (Pubitemid 38949921)
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383. (Pubitemid 17055592)
19. Badia X, Roset M, Montserrat S, et al. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc) 1999; 112 (Suppl 1): 79-85.
20. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as ameasure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7): 581-586. (Pubitemid 29296676)
21. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006; 73(3): 285-295. (Pubitemid 43739190)
22. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64(8): 728-735.
23. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12: 127.
24. Miravitlles M. The overlap syndrome between asthma and COPD: implications for management. Hot Topics Respir Dis 2011: 16: 15-20.
25. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect mis diagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003; 123(4): 1066-1072. (Pubitemid 36444362)
26. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124(2): 474-481. (Pubitemid 37000122)
27. Miravitlles M, Murio C, Guerrero T, Segú JL. [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care]. Arch Bronconeumol 1999; 35(4): 173-178.
28. Miravitlles M, Calle M, Alvarez-Gutierrez F, et al. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res 2006; 15(3): 471-480.
29. Llor C, Naberan K, Cots JM, et al. [Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease]. Arch Bronconeumol 2006; 42(4): 175-182.
30. Monteagudo M, Rodriguez-Blanco T, Parcet J, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol 2011; 47(5): 226-233.
31. Izquierdo Alonso JL, Rodríguez González-Moro JM, de Lucas Ramos P, et al. [Has the treatment of COPD changed in Spain? Results of a community multicenter study (VICE)]. Rev Clin Esp 2008; 208(1): 18-25.
32. de Miguel Díez J, Izquierdo Alonso JL, Rodríguez González-Moro JM, et al. [Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols]. Arch Bronconeumol 2003; 39(5): 195-202.